Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma melatonin concentrations in depression.

I M McIntyre, F K Judd, T R Norman

    The Australian and New Zealand Journal of Psychiatry
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Positive well-being during the menopausal transition: a systematic review.

    Climacteric : the journal of the International Menopause Society·2014
    Same author

    Relaxation theory and practice.

    The Australian journal of physiotherapy·2014
    Same author

    Relaxation, the physiotherapist and the psychiatric patient.

    The Australian journal of physiotherapy·2014
    Same author

    A multidimensional approach to the assessment of pain.

    The Australian journal of physiotherapy·2014
    Same author

    Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol.

    International journal of psychiatry in clinical practice·2014
    Same author

    Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.

    International clinical psychopharmacology·2004
    Same journal

    Cardiometabolic screening, elevated results and clinical follow-up actions in Ma-ori and non-Ma-ori with psychosis in Canterbury, Aotearoa New Zealand.

    The Australian and New Zealand journal of psychiatry·2026
    Same journal

    Author reply to Letter to the Editor regarding 'Middle childhood profiles of social-emotional competencies and difficulties differentiate risk of health service presentations with adolescent mental disorders'.

    The Australian and New Zealand journal of psychiatry·2026
    Same journal

    Letter to the Editor regarding 'Middle childhood profiles of social-emotional competencies and difficulties differentiate risk of health service presentations with adolescent mental disorders'.

    The Australian and New Zealand journal of psychiatry·2026
    Same journal

    Diagnostic complexity and comorbidity: Implications for identification, outcomes, health care and involuntary treatment.

    The Australian and New Zealand journal of psychiatry·2026
    Same journal

    Defining and measuring psychosocial disability in Australia: Assessment of national surveys and administrative datasets.

    The Australian and New Zealand journal of psychiatry·2026
    Same journal

    Academic performance in children of mothers with perinatal depressive disorder.

    The Australian and New Zealand journal of psychiatry·2026
    See all related articles

    Depressed patients show lower levels of the pineal hormone melatonin. This finding may link melatonin to beta-adrenoceptor changes in depression.

    Area of Science:

    • Neuroendocrinology
    • Psychiatry
    • Chronobiology

    Background:

    • Melatonin, a pineal hormone, plays a role in regulating sleep-wake cycles.
    • Alterations in melatonin secretion have been observed in various psychiatric conditions.
    • Depression is associated with complex neurobiological changes, including potential disruptions in hormonal regulation.

    Purpose of the Study:

    • To investigate melatonin levels in patients diagnosed with depression.
    • To compare plasma melatonin concentrations between depressed individuals and healthy controls.
    • To explore the potential implications of melatonin levels for understanding neurobiological mechanisms in depression, specifically beta-adrenoceptor function.

    Main Methods:

    • Measurement of plasma melatonin concentrations.

    Related Experiment Videos

  • Utilized midnight blood samples for melatonin assays.
  • Comparison of melatonin levels between a cohort of 11 depressed patients and 18 control subjects.

    • Main Results:

    • Significantly lower plasma melatonin concentrations were observed in the group of depressed patients compared to control subjects.
    • A clear distinction in melatonin levels was found between the two study groups.
    • The findings provide quantitative evidence for altered melatonin secretion in depression.

    Conclusions:

    • Reduced melatonin levels in depressed patients suggest a potential role for this hormone in the pathophysiology of depression.
    • The observed decrease in melatonin may be linked to theories of beta-adrenoceptor subsensitivity in depression.
    • Further research is warranted to elucidate the precise mechanisms connecting melatonin, beta-adrenoceptors, and depressive disorders.